Effect of the Baseline Use of Angiotensin-Converting Enzyme Inhibitors (ACEIs) or Angiotensin-Receptor Blockers (ARBs) on Outcomes of Patients With Suspected or Positive COVID-19 Infection

被引：0
|
作者：
Muhlestein, Joseph B.
Knowlton, Kirk U.
May, Heidi T.
Knight, Stacey
Bair, Tami L.
Le, Viet T.
Horne, Benjamin D.
Anderson, Jeffrey L.
机构：
来源：
CIRCULATION | 2020年 / 142卷
关键词：
D O I：
10.1161/circ.142.suppl_3.16745
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A16745
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Relating angiotensin-converting enzyme inhibitors or angiotensin receptor blockers with incidence or mortality of COVID-19
    Wong, Martin C. S.
    Wong, Sunny
    Huang, Junjie
    Yan, Bryan
    ESC HEART FAILURE, 2020, 7 (05): : 3119 - 3123
  • [32] Efficacy of Aliskiren for Patients with Hypertension Receiving Angiotensin-Converting Enzyme Inhibitors and/or Angiotensin-Receptor Blockers
    Fujino, Noboru
    Araki, Tsutomu
    Yasuda, Toshihiko
    Terai, Hidenobu
    Konno, Tetsuo
    Sakata, Kenji
    Hayashi, Kenshi
    Kawashiri, Masaaki
    Ino, Hidekazu
    Yamagishi, Masakazu
    JOURNAL OF CARDIAC FAILURE, 2013, 19 (10) : S157 - S157
  • [33] Ethnic Prevalence of Angiotensin-Converting Enzyme Deletion (D) Polymorphism and COVID-19 Risk: Rationale for Use of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers
    Rangaprasad Sarangarajan
    Robert Winn
    Michael A. Kiebish
    Chas Bountra
    Elder Granger
    Niven R. Narain
    Journal of Racial and Ethnic Health Disparities, 2021, 8 : 973 - 980
  • [34] Ethnic Prevalence of Angiotensin-Converting Enzyme Deletion (D) Polymorphism and COVID-19 Risk: Rationale for Use of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers
    Sarangarajan, Rangaprasad
    Winn, Robert
    Kiebish, Michael A.
    Bountra, Chas
    Granger, Elder
    Narain, Niven R.
    JOURNAL OF RACIAL AND ETHNIC HEALTH DISPARITIES, 2021, 8 (04) : 973 - 980
  • [35] Effect of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Outcomes in Patients with Alcoholic Cardioymopathy
    Selim, Ahmed M.
    Soghier, Israa
    Velankar, Pradnya
    Zolty, Ronald
    JOURNAL OF CARDIAC FAILURE, 2010, 16 (08) : S116 - S116
  • [36] Angiotensin-receptor blockers in prevention of cardiovascular events: are they as effective as angiotensin-converting enzyme inhibitors?
    Teo, Koon K.
    POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE, 2009, 119 (1-2): : 8 - 10
  • [37] Angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and prognosis of hypertensive patients hospitalised with COVID-19
    Covino, Marcello
    De Matteis, Giuseppe
    Burzo, Maria Livia
    Santoro, Michele
    Fuorlo, Mariella
    Sabia, Luca
    Sandroni, Claudio
    Gasbarrini, Antonio
    Franceschi, Francesco
    Gambassi, Giovanni
    INTERNAL MEDICINE JOURNAL, 2020, 50 (12) : 1483 - 1491
  • [38] COVID-19 and the use of angiotensin-converting enzyme inhibitors and receptor blockers. Scientific brief
    不详
    PEDIATRIA I MEDYCYNA RODZINNA-PAEDIATRICS AND FAMILY MEDICINE, 2020, 16 (01): : 120 - 121
  • [39] Association of Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Testing Positive for Coronavirus Disease 2019 (COVID-19)
    Mehta, Neil
    Kalra, Ankur
    Nowacki, Amy S.
    Anjewierden, Scott
    Han, Zheyi
    Bhat, Pavan
    Carmona-Rubio, Andres E.
    Jacob, Miriam
    Procop, Gary W.
    Harrington, Susan
    Milinovich, Alex
    Svensson, Lars G.
    Jehi, Lara
    Young, James B.
    Chung, Mina K.
    JAMA CARDIOLOGY, 2020, 5 (09) : 1020 - 1026
  • [40] Abnormalities of bradykinin in angioedema due to angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers
    Hosotte, M.
    Jarlot, S.
    Beaudouin, E.
    Morisset, M.
    Drouet, C.
    Kanny, G.
    ALLERGY, 2012, 67 : 501 - 501
12345